REVITADERM WOUND CARE GEL, (Benzalkonium Chloride in a gel containing transforming growth factor-b), 0.1%, packaged in 29.6 mL (1.0 FL OZ) bottles (NDC 63347-120-02) and 88.7 mL (3.0 FL OZ) tubes (NDC 63347-120-01), Blaine Labs Inc., Santa Fe Springs, CA 90670

This recall has been terminated (originally issued March 30, 2022).

Company

Blaine Labs Inc

Recall Initiated

January 25, 2022

Posted

March 30, 2022

Recall Number

D-0668-2022

Voluntary / Mandated

Voluntary: Firm initiated

Quantity

1119 (1 oz.) bottles/ 772 (3 oz.) tubes

Firm Location

Santa Fe Springs, CA, United States

Official Source

View on FDA website ↗